Screener
Biogen BIIB Accrued Manufacturing Costs
Accrued Manufacturing Costs at other companies
Other financials
Where this comes from
Reported directly by Biogen in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The source filing: Biogen’s 10-Q, filed July 29, 2026. Open the filing →
- Filed
- Jul 29, 2026, 6:36 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000875045-26-000075
FAQ
- What is Biogen's accrued manufacturing costs?
- Biogen (BIIB) reported accrued manufacturing costs of $391.3M in Q2 2026.
- How has Biogen's accrued manufacturing costs changed year-over-year?
- Biogen's accrued manufacturing costs increased by 50.0% year-over-year, from $260.9M to $391.3M.
- What is the long-term trend for Biogen's accrued manufacturing costs?
- Over 5 years (2020 to 2025), Biogen's accrued manufacturing costs has grown at a 2.4% compound annual growth rate (CAGR), from $333.8M to $375.8M.
Ask your AI about Biogen's accrued manufacturing costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude